Biotech Companies in Glasgow: 32 Active Firms (2026)
Biotech companies in Glasgow develop biological research, diagnostics and therapeutics within Scotland’s regulated life-sciences cluster.
Buying centres in this cohort tend to sit with translational research teams, diagnostics procurement, clinical-development groups and pharmaceutical partnering functions, rather than generic IT or facilities budgets. Buyers are usually research-led healthcare, pharma, clinical and life-sciences organisations, with a smaller public-sector route where validation, ethics and procurement cycles matter. Engagements are typically narrow in scope: contracted assays, platform access, validation packages, specialist supply or development work that must survive quality review. The commercial shape is closer to a small specialist operating company than a venture-only shell, with sales cycles shaped by evidence requirements, regulated workflows and the need to prove repeatability before wider adoption.
Read more
Glasgow has 32 actively trading biotech companies in this Glasgow cohort, making it a compact local market rather than a broad regional cluster. Across firms with employment disclosure, reported headcount totals 52, so the operating footprint appears small and specialist. Recent formation is still visible, with 5 companies incorporated since 2022, but the revenue profile is constrained: 0 firms report turnover above £5M. That points to a market made up mainly of research-stage, service-led or early-commercial businesses, where reported accounts may lag scientific progress and customer validation.
UK biotech and biopharmaceutical activity sits within the life-sciences regulatory framework, with obligations driven by the activity being conducted rather than by a uniform commercial rulebook. The MHRA sets standards and evaluates new treatments, including clinical trial applications, marketing authorisations and post-authorisation safety monitoring through pharmacovigilance. Clinical work also brings Good Clinical Practice, ethics review and informed-consent obligations into the sales process, even where a Glasgow supplier is providing enabling research rather than a finished medicine. Market access can add another stage: approved medicines may still face health technology assessment before routine public healthcare use. The BioIndustry Association and ABPI provide sector representation, but regulatory responsibility remains activity-specific.
Commercial progress appears tied to evidence packages, translational partnerships and the ability to move from project income into repeatable regulated work. The Glasgow cohort looks weighted towards small operating companies, so exits, licensing and partnerships may matter more than standalone scale for some teams. Buyers in pharma, clinical research and diagnostics tend to ask for reproducibility, quality systems and a clear route through approval or assessment. That favours firms with defensible biology and documented process control, while leaving thinner service businesses exposed to funding gaps and consolidation pressure.
What’s in the file
One row per company, 50+ columns — everything below plus each company’s verified directors, from Companies House filings.
Company data
Verified directors — included
32
Active firms
2026
5
Incorporated since 2022
younger Glasgow firms
£3.5 billion
2024 biotech equity
UK investment total
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Key facts
15% of the cohort was incorporated since 2022 (5 firms), so a sizeable share is in its first few filing cycles.
MHRA oversight includes clinical trial applications, marketing authorisations or drug licences, and post-authorisation pharmacovigilance.
Clinical trials must follow Good Clinical Practice, ethics review and informed-consent requirements.
UK life sciences generated £146.9 billion in turnover in 2023/2024 across 6,170 businesses; the biopharmaceutical subsector accounted for £98.9 billion, or 67% of turnover.
The UK accounted for 11.5% of global medical-sciences citations in 2023, behind the USA and China.
The UK’s global share of recruited patients in a subset of commercial trials was 2.6% in 2022, lifting its ranking from fifth to fourth among comparator countries.
Top Glasgow Biotech companies
Financial sub-scores
Computed from 4 filingsDevelops microRNA-based therapeutics for tendon disorders. Lead program TenoMiR is an injectable therapy targeting molecular pathways involved in tendinopathy to promote tendon repair. Conducts…
Targets patients with chronic tendon conditions such as elbow and shoulder tendinopathy, with future relevance to healthcare providers and systems treating musculoskeletal disease.
Financial Health
StableStable · -8% CAGR over 3y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsDevelops carbohydrate‑based technologies and ingredients for nutrition, over‑the‑counter, and prescription healthcare products. Applies carbohydrate science to create customised solutions for…
Serves B2B customers in the nutrition, OTC healthcare and prescription pharmaceutical sectors, including healthcare product developers and manufacturers, with customers and partners worldwide.
Financial Health
StableStable · -68% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 4 filingsFinancial Health
StableStable
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · -65% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 3 filingsFinancial Health
HealthyHealthy · 0% CAGR over 2y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 2 filingsFinancial Health
StableStable
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsFinancial Health
StrongStrong · Hiring · 32% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial Health
N/AN/A
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsProvides contract research services using human cardiomyocyte assays to assess cardiac safety and efficacy of drug candidates. Uses the CellOPTIQ platform to measure voltage, calcium, and…
Sells to pharmaceutical companies, biotech firms and regulatory agencies needing cardiac safety and efficacy testing for drug development. Targets R&D, safety pharmacology and toxicology teams…
Financial Health
StableStable · Hiring · 11% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsProvides transcriptomic and genomic analysis services using the TempO‑Seq platform for pharmaceutical, academic and clinical research. Supports drug discovery, biomarker identification and companion…
Serves pharmaceutical companies, academic research groups and clinical researchers working on drug discovery, companion diagnostics, biomarker development and molecular profiling.
Financial Health
StableStable · -10% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsDevelops and commercialises soft contact lenses using polyethylene glycol (PEG) polymer chemistry. Focuses on designing and manufacturing biocompatible contact lenses intended to improve comfort and…
Serves contact lens wearers, selling to consumers in the visioncare market seeking soft contact lenses focused on comfort and eye health.
Financial Health
StableStable · -7% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 3 filingsFinancial Health
StableStable
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
Financial sub-scores
Computed from 5 filingsFinancial Health
StableStable · 0% CAGR over 4y
Location
Buy this list of 115 companies
The complete list in one Excel/CSV file — company details, websites and key data. Yours to download and use.
98 more companies and their verified directors are in the file
You’re seeing the top 17. Buy the list to get all 115 with directors, websites and financials.
How Glasgow Biotech companies work and how to sell to them
What they do
Glasgow biotech firms usually earn revenue through project-based research work, diagnostic or assay services, specialist supply, platform access and, where biology is sufficiently protected, licence options with milestone or royalty terms. Pricing often starts as a defined statement of work: per-sample testing, per-study validation, fixed-fee development packages or access fees tied to a research programme. Subscription revenue is less common than in software, although data portals, testing panels and recurring lab services can create repeat purchasing. The sale is often a mix of laboratory delivery and evidence production, so the commercial asset is not just the biology but the documented protocol, quality trail and ability to repeat the result.
Who they sell to
Their customers are usually pharmaceutical, diagnostics, clinical research, university-linked and healthcare organisations, with public-sector procurement appearing where validation work touches public healthcare or grant-funded routes. Buying groups tend to include scientific sponsors first, then quality, regulatory, procurement and finance reviewers once a pilot moves towards a paid programme. Typical decision-makers include chief scientific officers, heads of translational medicine, clinical operations leads, pathology or lab managers, and procurement teams. Sales are commonly direct and relationship-led, often starting through conferences, academic networks or referrals. Formal RFPs are more likely for hospital, government or larger pharma work, and cycles can stretch where ethics, data access or sample governance must be resolved before contracting.
What they buy
Most Glasgow biotech firms tend to spend on tools and services that make lab work auditable, fundable and easier to hand over to partners. Relevant categories include laboratory information management, electronic lab notebooks, quality management systems, document control, bioinformatics, data storage, cyber security, sample logistics and equipment maintenance. Clinical or diagnostic teams may also buy regulatory affairs support, biostatistics, trial operations, health economics, validation services and specialist insurance. Smaller firms often need outsourced finance, grant administration, HR, recruitment and fractional commercial leadership because management teams are scientific by background. Sellers should expect careful scrutiny of integration with lab workflows, data integrity and evidence retention rather than a generic technology conversation.
Why and how to sell to them
Buying intent often appears when a research service becomes a repeatable customer offer, a diagnostic panel moves into validation, or a therapeutic programme prepares for regulated development. Funding, grants, new partnerships, senior scientific or quality hires, lab moves and preparation for MHRA-facing work are useful triggers. The common pain is not interest in the science; it is turning experiments into processes that customers, auditors and partners will trust. Outbound works better when it is framed around a named operational risk: reducing rework, tightening batch traceability, preparing evidence packs, improving sample turnaround, controlling regulated documents or giving partners clearer diligence material. Generic efficiency claims tend to land poorly.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Glasgow
Related directories
Frequently asked questions
How many biotech companies are there in Glasgow?
What counts as a biotech company in this list?
Which are the largest biotech companies in Glasgow?
What do biotech companies in Glasgow actually do?
How does Glasgow biotech compare internationally?
How is this list built and how fresh is the data?
How big are the typical biotech companies in Glasgow?
Are these mostly new or established biotech companies?
What SIC codes does this use?
What buying signals should I look for?
Buy all 115 companies as a spreadsheet.
One Excel/CSV file with company details, websites and key data — yours to download and use.